Related references
Note: Only part of the references are listed.Factors influencing varicella zoster virus infection after allogeneic peripheral blood stem cell transplantation: low-dose acyclovir prophylaxis and pre-transplant diagnosis of lymphoproliferative disorders
D. H. Kim et al.
TRANSPLANT INFECTIOUS DISEASE (2008)
Bortezomib in combination with intermediate-dose dexamethasone and continuous low-dose oral cyclophosphamide for relapsed multiple myeloma
Martin Kropff et al.
BRITISH JOURNAL OF HAEMATOLOGY (2007)
The high incidence of varicella herpes zoster with the use of bortezomib in 10 patients
Yin Tong et al.
AMERICAN JOURNAL OF HEMATOLOGY (2007)
Immunodeficiency and immunotherapy in multiple myeloma
Guy Pratt et al.
BRITISH JOURNAL OF HAEMATOLOGY (2007)
Bortezomib plus melphalan and prednisone in elderly untreated patients with multiple myeloma:: results of a multicenter phase 1/2 study
Maria-Victoria Mateos et al.
BLOOD (2006)
The effect of low-dose aciclovir on reactivation of varicella zoster virus after allogeneic haemopoietic stem cell transplantation
KJ Thomson et al.
BONE MARROW TRANSPLANTATION (2005)
Antimicrobial prophylaxis in hematopoietic stem cell transplant recipients: heterogeneity of current clinical practice
S Trifilio et al.
BONE MARROW TRANSPLANTATION (2004)
Long-term low-dose acyclovir against varicella-zoster virus reactivation after allogeneic hematopoietic stem cell transplantation
Y Kanda et al.
BONE MARROW TRANSPLANTATION (2001)
Share Paper
